default logo


Flow Cytometry

This powerful technique enables rapid identification and sorting of cells, streamlining the manufacture of many biologic pharmaceuticals. In the manufacture of many types of biologics, flow cytometry is a crucial tool for identifying, analyzing and sorting cells. This technique can pr
Continue Reading →

Upstream and Downstream Bioprocess Optimization

Improvements throughout the pipeline bring greater biologic yields, as well as higher quality. Bioprocessing is the production of natural or genetically manipulated cells (or other organic parts). In the field of biologic pharmaceuticals, bioprocessing is used to generate proteins lik
Continue Reading →

Vector Development

The creation, production and storage of viral vectors all pose highly unusual challenges. Traditional viral vaccines use attenuated or inactivated forms of viruses to trigger and “train” the body’s immune responses. In recent years, however, pharmaceutical developers have also begun t
Continue Reading →

BSL-3 Biologic Development

Advances in Biological Safety Level 3 technology offer advantages for agile biologic developers. Many types of biologics include live populations of organisms, some of which may be highly infectious in active form. Vaccines, in particular, often contain deadly bacteria and viruses in
Continue Reading →

Biologics Process Development

As the market expands, developers need support from expert contractors. A growing number of pharmaceutical development companies are partnering with contract manufacturing organizations (CMOs) to meet the global demand for biologics. This investment comes with good reason: as of 2016,
Continue Reading →

New Investments and Approvals Spur the Development of Biologics

Although still expensive to develop and produce, large molecules are rapidly taking over. For most of the previous century, much of pharmaceutical research focused on the development of small-molecule “blockbuster” drugs, which treated a wide variety of diseases for a great number of
Continue Reading →

Sterile Injectables for Clinical Trials

Growth continues, but logistical and regulatory hurdles limit worldwide supplies The global market for sterile injectables continues to expand at an impressive rate. In 2015, this market was valued at $299.7 billion; and its compound annual growth rate (CAGR) is projected at 6.9 perce
Continue Reading →